Novo Nordisk will slash US list prices of its blockbuster diabetes and weight-loss drugs Ozempic and Wegovy by up to 35% and 50% respectively starting next year, said the Danish drugmaker. #novonordisk #wegovy #ozempic #health #News #Reuters #Newsfeed Read the story here: https://reut.rs/4aJkQ00 👉 Subscribe: http://smarturl.it/reuterssubscribe Keep up with the latest news from around the world: https://www.reuters.com/ Follow Reuters on Facebook: https://www.facebook.com/Reuters Follow Reuters

Tag-uri: Facebook